Exelixis EP Line Announcement

[Kevin Cook]

Exelixis EP Line Announcement

Colleagues,
We are in the process of consolidating the fly collection at Exelixis and 
are working towards the goal of making larger numbers of our fly stocks 
available to the not-for-profit Drosophila research community. As part of 
this initiative, we will no longer serve as the US distribution center for 
the Rorth collection EP stocks. To effect a smooth transition, and to 
ensure that the most valuable stocks will continue to be easily obtained by 
the fly community, we are collaborating closely with both the Gene 
Disruption Project (GDP) and the Bloomington Stock Center. As part of this 
process, the GDP has analyzed the genes tagged by the Rorth/EP collection, 
conducted side-by-side comparisons with existing transposon tagged lines, 
and has selected 400 stocks for retention at Bloomington. These stocks tag 
novel genes and were chosen to complement the increasing number of 
insertion lines available through the efforts of the GDP (see 
http://flypush.imgen.bcm.tmc.edu/pscreen/).  We are working with the 
Bloomington Stock Center to facilitate the transfer of these stocks as soon 
as possible. The entire insertion collection, in addition to the X 
insertion lines already held at Bloomington, is still available from the 
Szeged center in Europe.

If you have questions regarding insertions selected by the GDP, please 
contact Hugo Bellen at hbellen at bcm.tmc.edu. Any specific correspondence for 
Exelixis may be directed to Helen Francis-Lang: helen at exelixis.com


---